Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Takhzyro Market Report 2025

Takhzyro Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Clinical Indication (Hereditary Angioedema (HAE) Prophylaxis, Hereditary Angioedema (HAE) Acute Attacks Treatment, Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Pediatric, Adult, Geriatric)

Takhzyro Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Takhzyro Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Takhzyro Market Definition

Takhzyro (lanadelumab-flyo) is a prescription medication used to prevent attacks of hereditary angioedema (HAE) in individuals aged 2 years and older. It functions as a monoclonal antibody that inhibits plasma kallikrein, reducing bradykinin levels and thereby decreasing the frequency and severity of swelling episodes associated with HAE.

The main types of indications for takhzyro are hereditary angioedema (HAE) prophylaxis, hereditary angioedema (HAE) acute attacks treatment, and other indications. Hereditary angioedema (HAE) prophylaxis refers to preventive treatment aimed at reducing the frequency and severity of angioedema attacks in individuals with HAE. It is distributed through various distribution channels, such as hospital pharmacies, retail pharmacies, and online pharmacies and it is used by several end users, including pediatric, adult, and geriatric.

Takhzyro Market Segmentation

The takhzyro market covered in this report is segmented –

1) By Clinical Indication: Hereditary Angioedema (HAE) Prophylaxis; Hereditary Angioedema (HAE) Acute Attacks Treatment; Other Indications

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

3) By End User: Pediatric; Adult; Geriatric

Takhzyro Market Size and growth rate 2025 to 2029: Graph

Takhzyro Market Size 2025 And Growth Rate

The takhzyro market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to an increase in investment in rare diseases, target population growth, improved healthcare infrastructure, an increase in global health initiatives for rare diseases, and geographic expansion.

Takhzyro Market Growth Forecast

The takhzyro market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to shifting towards personalized treatments in healthcare, an aging population, shifting towards prophylactic treatments, the prevalence of hereditary angioedema (HAE), and the increasing use of telemedicine. Major trends in the forecast period include digital and AI integration, adoption of precision medicine, advanced drug delivery systems, technological advancements, and integration of digital health technologies.

Book your 30 minutes free consultation with our research experts

Contact Us

Takhzyro Market Driver: Rising Prevalence Of Hereditary Angioedema (HAE) Driving The Market Growth

The prevalence of hereditary angioedema (HAE) is expected to propel the growth of the takhzyro market going forward. Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent, severe swelling in various body parts, often affecting the airway, and can be life-threatening. Rising cases of hereditary angioedema (HAE) are attributed to increased awareness, improved genetic testing, and the identification of spontaneous mutations in the C1 inhibitor gene, alongside environmental triggers. Takhzyro (lanadelumab) is used to prevent attacks of hereditary angioedema (HAE) by inhibiting kallikrein, thereby reducing bradykinin levels and the frequency and severity of swelling episodes. For instance, in June 2022, according to Rare Disease Advisor, a US-based nonprofit organization, hereditary angioedema (HAE) affects approximately 1 in 50,000 people globally, with prevalence estimates ranging from 1:10,000 to 1:150,000. It accounts for about 2% of all clinical angioedema cases. Therefore, the prevalence of hereditary angioedema (HAE) is driving the growth of the takhzyro market.

Takhzyro Market Driver: Growing Healthcare Expenditure Fuels Expansion Of The Market

The growing healthcare expenditure is significantly driving the growth of the takhzyro market in the future. Healthcare expenditure refers to the total amount spent on health services and related activities within a certain period, typically measured annually. Growing healthcare expenditure is due to an aging population, chronic diseases, higher service prices, increased demand, technological advancements, rising drug costs, the COVID-19 impact, medical inflation, and income polarization. Rising healthcare expenditure drives demand for effective treatments such as takhzyro, influencing pricing and cost-effectiveness evaluations in the market. For instance, in November 2024, according to Eurostat, a Luxembourg-based Directorate-General of the European Commission, in 2022, Germany emerged as the leader in EU healthcare expenditure, allocating approximately $520 billion, followed by France at $340 billion, Italy at $190 billion, and Spain at $140 billion. This represents a significant year-over-year increase compared to 2021, when Germany invested $500 billion, France $320 billion, Italy $180 billion, and Spain $130 billion in healthcare. Therefore, the growing healthcare expenditure is driving the growth of the takhzyro market.

Global Takhzyro Market Major Players

Major companies operating in the takhzyro market are Takeda Pharmaceuticals Inc.

Global Takhzyro Market Trend: Advancements In Pediatric Prophylaxis Treatment For Hereditary Angioedema (HAE)

The key trend in the takhzyro market is focusing on developing advanced pediatric prophylaxis treatment to gain prevention in attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older. Prophylaxis treatment refers to preventive measures taken to guard against disease or infection. This includes administering medications or vaccinations before potential exposure to pathogens. For instance, in February 2023, Takeda Pharmaceutical Company, a Japan-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental biologics license application (sBLA) for the expanded use of TAKHZYRO (lanadelumab-flyo) for prophylaxis to prevent attacks of hereditary angioedema (HAE) in pediatric patients 2 to <12 years of age. The sBLA approval was supported by extrapolation of efficacy data from the HELP Study, a Phase 3 trial that included patients 12 to <18 years of age.

Regional Analysis For The Global Takhzyro Market

North America was the largest region in the takhzyro market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the takhzyro market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the takhzyro market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Takhzyro Market?

The takhzyro market consists of sales of single-dose prefilled syringes, single-dose vials, and ready-to-use solutions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Takhzyro Industry?

The takhzyro market research report is one of a series of new reports from The Business Research Company that provides takhzyro market statistics, including the takhzyro industry global market size, regional shares, competitors with the takhzyro market share, detailed takhzyro market segments, market trends, and opportunities, and any further data you may need to thrive in the takhzyro industry. This takhzyro market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Takhzyro Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The takhzyro market covered in this report is segmented –
1) By Clinical Indication: Hereditary Angioedema (HAE) Prophylaxis; Hereditary Angioedema (HAE) Acute Attacks Treatment; Other Indications
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By End User: Pediatric; Adult; Geriatric
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Takeda Pharmaceuticals Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Takhzyro Market Characteristics

    3. Takhzyro Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Takhzyro Market Trends And Strategies

    5. Takhzyro Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Takhzyro Growth Analysis And Strategic Analysis Framework

    6.1. Global Takhzyro PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Takhzyro Market Growth Rate Analysis

    6.4. Global Takhzyro Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Takhzyro Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Takhzyro Total Addressable Market (TAM)

    7. Global Takhzyro Pricing Analysis & Forecasts

    8. Takhzyro Market Segmentation

    8.1. Global Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hereditary Angioedema (HAE) Prophylaxis

    Hereditary Angioedema (HAE) Acute Attacks Treatment

    Other Indications

    8.2. Global Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    8.3. Global Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Pediatric

    Adult

    Geriatric

    9. Global Takhzyro Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Takhzyro Market Regional And Country Analysis

    10.1. Global Takhzyro Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Takhzyro Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Takhzyro Market

    11.1. Asia-Pacific Takhzyro Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Takhzyro Market

    12.1. China Takhzyro Market Overview

    12.2. China Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Takhzyro Market

    13.1. India Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Takhzyro Market

    14.1. Japan Takhzyro Market Overview

    14.2. Japan Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Takhzyro Market

    15.1. Australia Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Takhzyro Market

    16.1. South Korea Takhzyro Market Overview

    16.2. South Korea Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Takhzyro Market

    17.1. Western Europe Takhzyro Market Overview

    17.2. Western Europe Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Takhzyro Market

    18.1. UK Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Takhzyro Market

    19.1. Germany Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Takhzyro Market

    20.1. France Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Takhzyro Market

    21.1. Eastern Europe Takhzyro Market Overview

    21.2. Eastern Europe Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Takhzyro Market

    22.1. North America Takhzyro Market Overview

    22.2. North America Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Takhzyro Market

    23.1. USA Takhzyro Market Overview

    23.2. USA Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Takhzyro Market

    24.1. Canada Takhzyro Market Overview

    24.2. Canada Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Takhzyro Market

    25.1. South America Takhzyro Market Overview

    25.2. South America Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Takhzyro Market

    26.1. Middle East Takhzyro Market Overview

    26.2. Middle East Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Takhzyro Market

    27.1. Africa Takhzyro Market Overview

    27.2. Africa Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Takhzyro Market Competitive Landscape And Company Profiles

    28.1. Takhzyro Market Competitive Landscape

    28.2. Takhzyro Market Company Profiles

    28.2.1. Takeda Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

    29. Global Takhzyro Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Takhzyro Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Takhzyro Market

    32. Recent Developments In The Takhzyro Market

    33. Takhzyro Market High Potential Countries, Segments and Strategies

    33.1 Takhzyro Market In 2029 - Countries Offering Most New Opportunities

    33.2 Takhzyro Market In 2029 - Segments Offering Most New Opportunities

    33.3 Takhzyro Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Takhzyro Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Takhzyro Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Takeda Pharmaceuticals Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Takhzyro Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Takhzyro Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, Takhzyro Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Takhzyro Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Takhzyro Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Takeda Pharmaceuticals Inc. Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Protein Purification And Isolation Market 2022 – Market Opportunities And Strategies

Read More

What Is The Pharmaceutical Processing Seals Market Overview In 2022?

Read More

Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the microbiome market research report 2022 with industry size, share, segments and market growth

Read More

Transdermal Skin Patches Market 2023 – By Product (Matrix, Drug In Adhesive, Reservoir, Vapor), By Type (Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Estradiol Transdermal Patch, Clonidine Transdermal Patch, Testosterone Transdermal Patch, Other Types), By Distribution Channel (Pain Relief, Nicotine Cessation, Hormone Replacement Therapy, Neurological Disorders, Cardiovascular Disorders, Other Applications), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Skin Booster Global Market Report 2025 – By Type (Mesotherapy, Micro-Needle), By Gender (Male, Female), By End-Use (Dermatology Clinics, MedSpa) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Skin Cancer Diagnostics Global Market Report 2025 – By Cancer Type (Basal Cell Carcinoma, Squamous Cell Carcinoma, Malignant Melanoma, Other Cancer Types), By Type (Diagnosis, Therapeutics), By Application (Hospital, Clinic, Laboratory, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Skincare Global Market Report 2025 – By Product Type (Creams, Lotions, Powders, Sprays, Other Products), By Packaging Type (Tube, Bottle, Jar, Other Packaging), By Gender (Men, Women), By Distribution channel (Stores, Supermarkets, Online, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Complicated Skin And Skin Structure Infections Drugs Global Market Report 2025 – By Active Ingredients (Delafloxacin, Vancomycin, Ceftaroline Fosamil, Linezolid, Other Active Ingredients), By Route of Administration (Oral, Topical, Parenteral), By End User (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hereditary Angioedema Therapeutics Global Market Report 2025 – By Drug Class (C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor, Other Drug Classes), By Route of Administration (Intravenous, Subcutaneous, Oral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels), By Application (Prophylaxis, On-demand) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Skin Cancer Drugs Global Market Report 2025 – By Type (Actinic Keratoses (AK), Basal cell carcinoma (BCC), Squamous cell carcinoma (SCC), Melanoma), By Drug Class (Chemotherapy, Immunotherapy, Targeted Agents & Other Drugs), By End Users (Hospitals, Cancer Research Centers, Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Transdermal Skin Patches Global Market Report 2025 – By Product (Matrix, Drug In Adhesive, Reservoir, Vapor), By Type (Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Estradiol Transdermal Patch, Clonidine Transdermal Patch, Testosterone Transdermal Patch, Other Types), By Distribution Channel (Pain Relief, Nicotine Cessation,Hormone Replacement Therapy, Neurological Disorders, Cardiovascular Disorders, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Takhzyro market?

Takhzyro (lanadelumab-flyo) is a prescription medication used to prevent attacks of hereditary angioedema (HAE) in individuals aged 2 years and older. It functions as a monoclonal antibody that inhibits plasma kallikrein, reducing bradykinin levels and thereby decreasing the frequency and severity of swelling episodes associated with HAE. For further insights on the Takhzyro market, request a sample here

How will the Takhzyro market drivers and restraints affect the market dynamics? What forces will shape the Takhzyro industry going forward?

The Takhzyro market major growth driver - Rising Prevalence Of Hereditary Angioedema (HAE) Driving The Market Growth. For further insights on the Takhzyro market, request a sample here

What is the forecast market size or the forecast market value of the Takhzyro market?

The Takhzyro market size has grown strongly in recent years. The takhzyro market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to an increase in investment in rare diseases, target population growth, improved healthcare infrastructure, an increase in global health initiatives for rare diseases, and geographic expansion. The takhzyro market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to shifting towards personalized treatments in healthcare, an aging population, shifting towards prophylactic treatments, the prevalence of hereditary angioedema (HAE), and the increasing use of telemedicine. Major trends in the forecast period include digital and AI integration, adoption of precision medicine, advanced drug delivery systems, technological advancements, and integration of digital health technologies. For further insights on the Takhzyro market, request a sample here

How is the Takhzyro market segmented?

The takhzyro market covered in this report is segmented –
1) By Clinical Indication: Hereditary Angioedema (HAE) Prophylaxis; Hereditary Angioedema (HAE) Acute Attacks Treatment; Other Indications
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By End User: Pediatric; Adult; Geriatric For further insights on the Takhzyro market, request a sample here

Which region has the largest share of the Takhzyro market? What are the other regions covered in the report?

North America was the largest region in the takhzyro market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the takhzyro market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Takhzyro market, request a sample here.

Who are the major players in the Takhzyro market?

Major companies operating in the takhzyro market are Takeda Pharmaceuticals Inc. . For further insights on the Takhzyro market, request a sample here.

What are the key trends in the Takhzyro market?

Major trends in the Takhzyro market include Advancements In Pediatric Prophylaxis Treatment For Hereditary Angioedema (HAE). For further insights on the Takhzyro market, request a sample here.

What are the major opportunities in the Takhzyro market? What are the strategies for the Takhzyro market?

For detailed insights on the major opportunities and strategies in the Takhzyro market, request a sample here.

How does the Takhzyro market relate to the overall economy and other similar markets?

For detailed insights on Takhzyro's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Takhzyro industry?

For detailed insights on the mergers and acquisitions in the Takhzyro industry, request a sample here.

What are the key dynamics influencing the Takhzyro market growth? SWOT analysis of the Takhzyro market.

For detailed insights on the key dynamics influencing the Takhzyro market growth and SWOT analysis of the Takhzyro industry, request a sample here.